DISEASE INDICATIONS: Progressive Familial Intrahepatic Cholestasis
MANUFACTURER: Albireo Pharma
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Bylvay, known by its generic name Odevixibat, is a pharmaceutical medication used to treat a rare genetic disorder known as progressive familial intrahepatic cholestasis (PFIC).
DISEASE INDICATIONS:
Alagille syndrome
MANUFACTURER:
Mirum Pharmaceuticals
USAGE:
Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Livmarli (maralixibat) is a prescription medication that belongs to the drug class of bile acid transporter inhibitors. It is used to treat cholestatic pruritus (itch) in patients with Alagille syndrome who are at least 1 year old.
DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)
MANUFACTURER: Intercept Pharma Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Ocaliva, known by its generic name Obeticholic Acid, is a medication used to treat certain liver disorders, primarily primary biliary cholangitis (PBC). It is also being investigated for its potential use in other liver-related conditions.